EPIDEMIOLOGY OF TESTICULAR CANCER
Abstract
This review article, devoted to the study of the epidemiology of testicular tumors, presents the analysis of global statistics on oncological diseases, collected from the materials of the World Health Organization (WHO), especially from the International Agency for Research on Cancer, as well as from the GLOBOCAN database. The article highlights the key trends in the incidence of disease and survival of patients with testicular cancer in various regions, including the countries of America, Western, Eastern and Central Europe, as well as the states of the Middle East and East Asia, Southeast and Central Asia. In parallel, statistical data are provided for the CIS countries. Particular attention is paid to the prevalence of this pathology in the Republic of Uzbekistan. Further, testicular cancer is considered in the light of the etiopathogenesis of carcinogenesis. The risks associated with the development of this disease have various aspects, but are united by a common pathogenetic mechanism: long-term hormonal imbalance in the male body, as well as hereditary and genetic factors, such as a personal or family history of testicular cancer and the presence of hereditary mutations. In addition, a link between ethnicity and the incidence of testicular cancer is highlighted, which emphasizes the importance of taking these factors into account in further research.
About the Authors
List of references
Okulov A. B., Mirakov K. K., Volodko E. A., Godlevsky D. N., Okulov E. A., Akhmina N. I., Anikiev A. V. Cryptorchidism: a retrospective and current issues. Pediatric Surgery 2017; 21(4): 202–206.
Degtyarev Yu. G., Akselrov M. A., Batsevich L. Hospital-replacing technologies in pediatric surgery. Various approaches. Pros and cons. Medical Science and Education of the Urals 2018; 19(2): 66–70.
Akilov F. A., Makhmudov A. T., Shavakhabov T. T., Mirkhamidov D. Kh. Comparative study of original questionnaires for assessing the premature ejaculation index. Experimental and Clinical Urology. 2016. - No. 2. - P. 102-107.
Akilov F.A., Rakhmonov O.M., Mirkhamidov D.Kh., Alijanov Zh.F. Evaluation of the reliability and validity of the Uzbek and Russian versions of the International Prostate Symptom Scale (IPSS) questionnaire // Experimental and Clinical Urology. - 2012. - No. 4. - P. 63-66.
Apolikhin O.I., Komarova V.A., Nikushina A.A., Sivkov A.V. Prostate diseases in the Russian Federation: statistical data 2008-2017. Experimental and Clinical Urology. - 2018. - No. 4. - P. 4–14.
Apolikhin O.I., Sivkov A.V. et al. Analysis of uronephrological morbidity in the Russian Federation based on official statistics. // Experimental and Clinical Urology, 2010. No. 2. P. 4-10.
Apolikhin O.I., Sivkov A.V., Komarova V.A., Nikushina A.A. Diseases of the prostate gland in the Russian Federation: statistical data 2008-2017. Urology Digest No. 5 2021, pp. 13-30.
Gamidov S.I., Popova A.Yu., Shatylko T.V., Li K.I., Safiullin R.I. Evaluation of the effectiveness of dapoxetine in primary and secondary forms of premature ejaculation. Urology 2022; 1:46–49.
Gevorkyan A.R. Urological service of municipal outpatient and polyclinic institutions taking into account modern economic approaches. Diss. Doc. of Medicine: spec. 14.01.23, 14.02.03 - Moscow. - 2021. - 385 p.
Giyasov Sh.I., Gafarov R.R., Shodmonova Z.R., Mukhtarov Sh.T., Akilov F.A. The role of systematization of postoperative complications in assessing the effectiveness and safety of surgical methods for the treatment of benign prostatic hyperplasia // Urology. - 2022. - No. 3. - P.83-91.
Golovachev S.V., Nurgaliev N.S., Kamarli Z.P., Makimbetov E.K. The state of oncological care and the epidemiology of prostate cancer in the Central Asian republics. Oncourology. - 2016. - V. 12. - No. 3. - P. 82-86.
Kulai D.G. Justification of antidiuretic therapy for benign prostatic hyperplasia. Diss. for the degree of Cand. Sci. (Medicine). St. Petersburg, 2017.
Prosyannikov M.Yu. Results of the implementation of a comprehensive staged standardized program for the diagnosis and treatment of benign prostatic hyperplasia. Social aspects of population health I 25/02/2015. URL: http://vestnic.mtdnet.ru
Potapov S.V., Galata D., Pliten O. Immunohistochemical assessment of proliferative-apoptotic processes in embryonic testicular cancer. Ukrainian journal of medicine, biology and sport. 2020; 1 (23): 72-78. (Ukrainian)
Pushkar D.Yu., Rasner P.I. Modern algorithm for examination and treatment of patients with prostate adenoma. Urology 2017;(3):87-93.
Rakhimov M.K. Early diagnosis of urinary tract diseases among the rural population of the Khorezm region of the Republic of Uzbekistan. Medical news. - 2016. - No. 6. - P. 60-62.
Sivkov, A.V. Benign prostatic hyperplasia: a personal view / A.V. Sivkov // Urology today. - 2016. - No. 6. - P. 7-11. 17. Tillyashaykhov M.N. Current state of the oncology service in Uzbekistan. Clinical and experimental oncology, No. 3 (5) - 2018. - P. 15-19.
Tkachuk, V.N. Benign hyperplasia of the prostate gland / V.N. Tkachuk, A.E. Lukyanov. St. Petersburg: SpetsLit, 2003. – 109 p. 19. Khairullaeva S.S., Khamraev A.A. On the effectiveness of spilactone in liver cirrhosis, the relationship between the diuretic response and the clinical course “Bulletin of the Association of Doctors of Uzbekistan. - 2021. - No. 4. - P. 66-68
Khairullaeva S.S. Liver diseases in pregnant women in the practice of a primary care physician Uzbekiston umumiy amaliyot vrachlari akhbo-rotnomasi.- 2018.- No. 1. - P. 31-32.
Shaykhova G.I. Low-protein diet for patients with chronic kidney disease Experimental and clinical gastroenterology. - 2019. - No. 12. - P. 135 –142.
Corona G. Erectile dysfunction and premature ejaculation: a continuum moves supporting couple sexual dysfunction. J Endocrinol Invest. 2022 Nov;45(11):2029-2041. doi:10.1007/s40618-022-01793-8. Epub 2022 May 3. PMID: 35503598; PMCID: PMC9063256.
EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam 2022. ISBN 978-94-92671-16-5.
Etter JL, Eng K, Cannioto R, et al. Hereditary association between testicular cancer and familial ovarian cancer: a family-based ovarian cancer registry study. Cancer Epidemiology. 2018;53:184–186.
Guessous I., Cullati S., Fedewa S.A. et al. Prostate cancer screening in Switzerland: 20-year trends and soc ioeconomic disparities. Prev Med 2016;82:83–91. DOI: 10.1016/ j.ypmed.2015.11.009
Maroto P, García del Muro X, Valverde C, et al. Incidence and clinical features of contralateral synchronous and metachronous testicular germ cell carcinoma. Urologic Oncology: Seminars & Original Research. 2021; 39(2):135.e17-135.e23.
Herget KA, Patel DP, Hanson HA et al. Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score. Cancer Med 2016;5(1): 136–41. DOI: 10.1002/cam4.549.
Park JS, Kim J, Elgyati A, Ham WS. Recent global trends in testicular cancer incidence and mortality. Medicine (Baltimore). 2018 Sep;97(37):e12390.
Lobo J, Costa AL, Vilela–Salgueiro B, et al. Testicular germ cell tumors: reexamination of a series in light of the new WHO classification and AJCC staging systems, with emphasis on pathologists’ concerns. Hum Pathol. 2018 Dec;82:113–30. Laksita TB, Kloping YP, Hakim L, Rizaldi F. Translation validity and reliability of the Indonesian version of the 5-item International Index of Erectile Function (IIEF-5). Turk J Urol. 2021 Nov;47(6):489-494. doi: 10.5152/tud.2021.21185.
Lim KB. Epidemiology of clinical benign prostatic hyperplasia. Asian J Urol. 2017 Jul;4(3):148-151. doi: 10.1016/j.ajur.2017.06.004. Epub 2017 Jun 9. PMID: 29264223; PMCID: PMC5717991.
Mustafa S.A., Mitla V., Bandai S.Z., Kuchai S. Profile of testicular germ cell tumors in Kashmir: a retrospective analysis. Int J Sci. 2017; 5(4):183-6
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.